Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa

van der Walt, ML; Shean, K; Becker, P; Keddy, KH; Lancaster, J

van der Walt, ML (corresponding author), South African Med Res Council, TB Platform, Pretoria, South Africa.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021; 65 (1):

Abstract

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) patients receiving ethambutol, cycloserine, or terizidone as part of a standardized......

Full Text Link